MedicineMolecular BiologyOncologyGene ExpressionMolecular OncologyTranscriptomicsCancer BiomarkersCancer TranscriptomicsColorectal CancerNoncoding Rna In CancerNoncoding Rna TranscriptomicsTranscriptomic ProfilingColorectal Cancer PrognosisLong Non-coding Ribonucleic AcidsLong Non-coding Rna BiomarkersLong Noncoding Rna BiomarkersLong Noncoding Rna Expression AnalysisNoncoding Rna Differential Expression AnalysisNoncoding Rna Expression ProfilingTnm Staging System
Colorectal cancer (CRC) is a disease with high incidence, especially in developed countries. Long non-coding RNAs (lncRNAs) are new research hotspots for their vital roles in regulating gene expression. This study aims to investigate the prognostic value of lncRNAs in CRC patients. A total of 21 cancer-related lncRNAs were detected by PCR array to reveal their expression changes in CRC tissue. A 120-week-long follow-up was performed in 30 CRC patients to analyze the relationship between lncRNA levels and CRC prognosis. Most of the 21 lncRNAs were differentially expressed in CRC tissue compared to the adjacent normal tissue, among which seven lncRNAs were significantly changed: AFAP1-AS1, BCAR4, H19, HOXA-AS2, MALAT1 and PVT1 were up-regulated, and ADAMTS9-AS2 was down-regulated in CRC tissue samples. No obvious correlation was found between lncRNA levels and the age, gender, tumor size or TNM stage of these patients. Log-rank test indicated that higher levels of AFAP1-AS1, BCAR4, H19, HOXA-AS2, MALAT1 or PVT1 and lower level of ADAMTS9-AS2 might predict the poor prognosis of CRC patients. This study suggests the potential value of the seven lncRNAs in the prognosis of CRC, providing reference information for future research on CRC prognostic and treatment strategy.
53
Comprehensive molecular characterization of human colon and rectal cancer
Colorectal cancer statistics, 2014
Rebecca L. Siegel, Carol DeSantis, Ahmedin Jemal · CA A Cancer Journal for Clinicians · 2014 · 2.6K citations · Full text